S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Income from Continuing Operations
â‚©19.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Income from Continuing Operations
â‚©1T
CAGR 3-Years
45%
CAGR 5-Years
34%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Income from Continuing Operations
-â‚©8.7B
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Income from Continuing Operations
-â‚©33.9B
CAGR 3-Years
3%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Income from Continuing Operations
-â‚©22.9B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Income from Continuing Operations
-â‚©5.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
19.8B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Income from Continuing Operations amounts to 19.8B KRW.

What is ST Pharm Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 1Y
23%

Over the last year, the Income from Continuing Operations growth was 23%.

Back to Top